logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure PPP-1. Indexed trends in EU retail prices for major drug types, adjusting for inflation, 2000-2005


1. The trends represent the available information on national street-level prices for each drug in the EU Member States and Norway, weighted by country population sizes to form an overall EU trend. Prices have been adjusted for national inflation rates (base year 2000) and all series indexed to a base of 100 in 2000.

2. Countries missing drug price information for two or more consecutive years are not included in the trend calculations for the drug: the trend for LSD is based on 6 countries, heroin brown on 7, amphetamine on 10, cocaine on 15, ecstasy on 15, herbal cannabis on 13, and cannabis resin on 16.

3. Additionally, where 2005 data are missing (6 cases) 2004 prices are used; for missing 2000 data (5 cases) 2001 prices are used; data missing for other years (18 cases) have been interpolated from adjacent years.


SB2006: Figure PPP-3 Inflation and population data: http://epp.eurostat.ec.europa.eu/

See also 'General notes for interpreting data' on the Explanatory notes and help page.


Price data: Reitox National Focal Points

Page last updated: Wednesday, 21 November 2007